Lamperti C, Zeviani M
Unit of Molecular Neurogenetics, "C. Besta" Neurological Institute - IRCCS Foundation, Milan, Italy.
Acta Myol. 2009 Jul;28(1):2-11.
Autosomal dominant Progressive External Ophthalmoplegias are Mendelian disorders characterized by the accumulation of multiple deletions of mitochondrial DNA in critical tissues. Most of the Autosomal dominant Progressive External Ophthalmoplegias families carry heterozygous mutations in one of three genes: ANT1, encoding the muscle-heart specific mitochondrial adenine nucleotide translocator, Twinkle, encoding the mitochondrial DNA helicase, and POLG1, encoding the catalytic subunit of the mitochondrial DNA-specific polymerase. Mutations in both POLG1 alleles are also found in autosomal recessive Progressive External Ophthalmoplegias sibships with multiple affected members and in apparently sporadic cases. In addition, recessive POLG1 mutations are responsible for three additional diseases: Alpers-Huttenlocher hepatopathic poliodystrophy, Sensory-Ataxic Neuropathy Dysarthria and Ophthalmoplegia and juvenile SpinoCerebellar Ataxia-Epilepsy syndrome. Mitochondrial neuro-gastro-intestinal encephalomyopathy is an autosomal recessive disorder of juvenile onset, caused by mutations in the gene encoding Thymidine Phosphorylase. Thymidine Phosphorylase is involved in the control and maintenance of the pyrimidine nucleoside pool of the cell. Finally, mitochondrial DNA depletion syndrome is a heterogeneous group of disorders characterized by a reduction in mitochondrial DNA copy number. Clinically, they include a myopathic form, a more generalized encephalomyopathic form and a fatal infantile hepato-cerebral syndrome leading to rapidly progressive liver and brain failure. To date, eight genes have been associated with mitochondrial DNA depletion syndrome. Novel disease genes have recently been added to this list, including OPA1 and GFER, and new clinical variants add further complexity to this expanding area of mitochondrial medicine.
常染色体显性遗传性进行性眼外肌麻痹是孟德尔疾病,其特征是关键组织中线粒体DNA多处缺失的积累。大多数常染色体显性遗传性进行性眼外肌麻痹家族在三个基因之一中携带杂合突变:ANT1,编码肌肉 - 心脏特异性线粒体腺嘌呤核苷酸转运体;Twinkle,编码线粒体DNA解旋酶;POLG1,编码线粒体DNA特异性聚合酶的催化亚基。在有多个患病成员的常染色体隐性遗传性进行性眼外肌麻痹同胞关系以及明显散发的病例中也发现了POLG1两个等位基因的突变。此外,隐性POLG1突变还导致另外三种疾病:阿尔珀斯 - 胡滕洛赫尔肝病性脑脊髓病、感觉性共济失调性神经病构音障碍和眼肌麻痹以及青少年脊髓小脑共济失调 - 癫痫综合征。线粒体神经胃肠性脑肌病是一种青少年发病的常染色体隐性疾病,由编码胸苷磷酸化酶的基因突变引起。胸苷磷酸化酶参与细胞嘧啶核苷池的控制和维持。最后,线粒体DNA耗竭综合征是一组异质性疾病,其特征是线粒体DNA拷贝数减少。临床上,它们包括肌病形式、更广泛的脑肌病形式和致命的婴儿肝脑综合征,导致快速进展的肝和脑衰竭。迄今为止,已有八个基因与线粒体DNA耗竭综合征相关。最近,新的疾病基因已被添加到这个列表中,包括OPA1和GFER,新的临床变异为这个不断扩大的线粒体医学领域增加了进一步的复杂性。